Access Statistics for Iain M. Cockburn

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Mixed Poisson Regression Model for Analysis of Patent Data 0 0 0 290 1 4 9 1,722
Are All Patent Examiners Equal? The Impact of Examiner Characteristics 0 0 0 364 0 0 13 1,947
Balancing Incentives: The Tension Between Basic and Applied Research 0 0 0 416 1 3 19 1,843
Characteristics of Demand for Pharmaceutical Products: an Examination of four Cephalosporins 0 0 0 0 0 2 10 2,341
Deals Not Done: Sources of Failure in the Market for Ideas 0 1 2 29 0 1 11 77
Do Patents Matter?: Empirical Evidence after GATT 0 0 2 290 1 1 12 798
Entry and Patenting in the Software Industry 0 1 2 188 1 2 11 613
Faster, Smaller, Cheaper: An Hedonic Price Analysis of PDAs 0 0 0 100 0 0 3 386
Generics and New Goods in Pharmaceutical Price Indexes 0 0 0 265 1 3 15 1,201
Gone But Not Forgotten: Labor Flows, Knowledge Spillovers, and Enduring Social Capital 0 0 0 259 0 0 6 800
Hedonic Analysis of Arthritis Drugs 0 0 0 162 0 0 8 1,007
Industry Effects and Appropriability Measures in the Stock Markets Valuation of R&D and Patents 0 2 6 374 2 4 18 1,113
Is Price Inflation Different for the Elderly? An Empirical Analysis of Prescription Drugs 0 0 0 154 0 0 6 1,619
Market Conditions and Retirement of Physical Capital: Evidence fron Oil Tankers 0 0 0 44 0 0 2 461
Measuring competence?: exploring firm effects in pharmaceutical research 1 2 5 505 2 8 42 1,293
Not Invented Here? Innovation in Company Towns 0 0 2 83 0 0 9 307
Patent Thickets, Licensing and Innovative Performance 0 1 1 128 0 1 8 386
Patent thickets, licensing and innovative performance 0 1 1 56 0 2 8 137
Patents and the Global Diffusion of New Drugs 0 0 2 71 1 4 27 125
Patents and the Global Diffusion of New Drugs 0 0 1 50 1 2 16 93
Patents and the Global Diffusion of New Drugs 0 0 1 29 1 4 21 79
Patents and the Survival of Internet-related IPOs 0 1 1 82 1 4 13 268
Patents and the global diffusion of new drugs 0 0 0 18 1 3 17 62
Patents and the global diffusion of new drugs 0 1 2 53 1 3 21 75
Patents, Thickets, and the Financing of Early-Stage Firms: Evidence from the Software Industry 0 0 0 98 1 1 8 319
Price Indexes for Clinical Trial Research: A Feasibility Study 1 1 1 21 2 4 10 49
Public & Private Spillovers, Location and the Productivity of Pharmaceutical Research 0 0 0 123 0 0 12 351
Public-Private Interaction and the Productivity of Pharmaceutical Research 0 0 0 185 0 1 18 739
Racing or spilling?: the determinants of research productivity in ethical drug discovery 0 1 1 52 0 2 16 184
Racing to invest?: the dynamics of competition in ethical drug discovery 1 3 6 288 2 6 22 570
Scale, Scope and Spillovers: The Determinants of Research Productivity in Drug Discovery 0 0 0 1 1 5 18 456
Scale, Scope and Spillovers: The Determinants of Research Productivity in the Pharmaceutical Industry 0 0 1 346 2 4 27 998
Scale, scope and spillovers: the determinants of research productivity in ethical drug discovery 0 0 0 144 2 3 18 308
The Diffusion of Science-Driven Drug Discovery: Organizational Change in Pharmaceutical Research 0 0 0 308 0 2 27 1,910
The Impact of Artificial Intelligence on Innovation 4 16 78 238 18 87 1,728 2,350
The Regulation of Prescription Drug Competition and Market Responses: Patterns in Prices and Sales Following Loss of Exclusivity 0 0 0 53 0 0 5 83
University Research, Industrial R&D, and the Anchor Tenant Hypothesis 0 0 0 223 1 4 23 906
Why are Some Regions More Innovative than Others? The Role of Firm Size Diversity 0 0 2 95 1 3 11 253
Why are some regions more innovative than others? The role of firm size diversity 0 0 0 83 1 2 9 69
Total Working Papers 7 31 117 6,268 46 175 2,277 28,298


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Absorptive Capacity, Coauthoring Behavior, and the Organization of Research in Drug Discovery 0 1 11 310 3 9 47 1,205
Access to intellectual property for innovation: Evidence on problems and coping strategies from German firms 0 1 4 20 0 1 12 104
Analysis of Patent Data--A Mixed-Poisson-Regression-Model Approach 0 0 0 0 0 1 11 902
Characteristics of Demand for Pharmaceutical Products: An Examination of Four Cephalosporins 0 0 0 404 0 1 3 1,135
Deals not done: Sources of failure in the market for ideas 0 0 2 4 0 0 17 50
Diffusion of New Drugs in the Post-TRIPS Era 0 0 1 50 0 0 4 157
Entry and Patenting in the Software Industry 0 2 5 40 1 5 18 208
Faster, smaller, cheaper: an hedonic price analysis of PDAs 1 2 3 39 3 7 26 229
Finding the Endless Frontier: Lessons from the Life Sciences Innovation System for Technology Policy 0 1 2 22 0 1 6 88
Generics and New Goods in Pharmaceutical Price Indexes 0 0 5 219 0 3 22 882
Generics and New Goods in Pharmaceutical Price Indexes: Reply 0 0 0 33 0 0 3 166
Industry Effects and Appropriability Measures in the Stock Market's Valuation of R&D and Patents 3 7 23 305 5 12 66 1,030
Information Technology and Intangible Output: The Impact of IT Investment on Innovation Productivity 1 3 5 7 3 7 18 32
Is Price Inflation Different for the Elderly? An Empirical Analysis of Prescription Drugs 0 0 0 28 0 3 11 368
Measuring Competence? Exploring Firm Effects in Pharmaceutical Research 0 0 4 5 1 3 27 39
New Pills for Poor People? Empirical Evidence after GATT 0 1 1 230 0 2 10 502
Not Invented Here? Innovation in company towns 1 3 4 31 1 6 22 277
Opportunity costs and entrepreneurial activity 1 5 9 127 4 12 53 372
Patent thickets, licensing and innovative performance 0 1 5 34 1 2 18 123
Patents and the Global Diffusion of New Drugs 0 0 5 68 3 10 49 302
Patents and the survival of Internet-related IPOs 1 1 6 72 3 11 35 326
Patents, Thickets and the Financing of Early-Stage Firms: Evidence from the Software Industry 0 1 1 70 0 2 15 309
Pharmaceutical Innovations and Market Dynamics: Tracking Effects on Price Indexes for Antidepressant Drugs 0 0 0 0 0 1 7 12
Pharmaceutical Innovations and Market Dynamics: Tracking Effects on Price Indexes for Antidepressant Drugs 0 0 0 2 0 1 9 14
Public & Private Spillovers: Location and the Productivity of Pharmaceutical Research 1 2 5 13 2 8 32 70
Racing to Invest? The Dynamics of Competition in Ethical Drug Discovery 0 0 0 0 1 7 26 600
Scale and scope in drug development: unpacking the advantages of size in pharmaceutical research 1 6 10 219 1 11 32 547
Scale, Scope, and Spillovers: The Determinants of Research Productivity in Drug Discovery 1 6 34 531 8 30 115 1,593
The Economics of Reproducibility in Preclinical Research 1 2 2 2 1 2 4 4
The Global Location of Biopharmaceutical Knowledge Activity: New Findings, New Questions 0 0 0 5 0 2 4 44
The Impact of Incremental Innovation in Biopharmaceuticals 0 0 0 11 0 0 3 44
The anchor tenant hypothesis: exploring the role of large, local, R&D-intensive firms in regional innovation systems 0 2 13 156 3 9 36 551
Untangling the origins of competitive advantage 0 0 0 0 0 1 7 10
Why are some regions more innovative than others? The role of small firms in the presence of large labs 1 2 8 62 5 10 41 240
Total Journal Articles 13 49 168 3,119 49 180 809 12,535


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Comment on "The Confederacy of Heterogeneous Software Organizations and Heterogeneous Developers: Field Experimental Evidence on Sorting and Worker Effort" 0 0 0 3 0 0 3 32
Comments on Nathan Rosenberg’s ‘Critical Episodes in the Progress of Medical Innovation’ 0 1 1 1 0 1 2 8
Finding the Endless Frontier: Lessons from the Life Sciences Innovation System for Energy R&D 0 1 2 19 0 1 6 69
Hedonic Analysis of Arthritis Drugs 0 0 1 15 0 0 6 59
Is Price Inflation Different for the Elderly? An Empirical Analysis of Prescription Drugs 0 0 0 8 0 0 6 71
Is the Pharmaceutical Industry in a Productivity Crisis? 0 0 2 71 0 2 9 398
Not Invented Here? Innovation in Company Towns 0 0 0 0 1 1 9 162
Patents, Thickets and the Financing of Eastly-Stage Firms; Evidence from the Software Industry 0 0 0 22 0 1 9 111
Public and Private Spillovers: Location and the Productivity of Pharmaceutical Research 0 0 0 0 1 2 9 87
Publicly Funded Science and the Productivity of the Pharmaceutical Industry 0 1 4 72 4 8 31 216
The Global Location of Biopharmaceutical Knowledge Activity: New Findings, New Questions 0 0 0 15 0 0 1 64
The Impact of Artificial Intelligence on Innovation: An Exploratory Analysis 11 33 93 206 22 67 266 545
The Regulation of Prescription Drug Competition and Market Responses: Patterns in Prices and Sales following Loss of Exclusivity 0 0 2 18 2 5 17 82
Total Chapters 11 36 105 450 30 88 374 1,904


Statistics updated 2020-08-05